MFAP5 facilitates the aggressiveness of intrahepatic Cholangiocarcinoma by activating the Notch1 signaling pathwayJianhui Li(Sun Yat-sen University), Xiaoyu Yin(Verizon (United States))Journal of Experimental & Clinical Cancer ResearchNovember 27, 201910.1186/s13046-019-1477-4Cited by 45SaveCiteExport RISWatch citationsRelated PapersGunagratinib, a highly selective irreversible FGFR inhibitor, in patients with previously treated locally advanced or metastatic cholangiocarcinoma harboring FGFR pathway alterations: A phase IIa dose-expansion study.|Journal of Clinical Oncology|2023|11